This article explores the global prevalence of autonomic neuropathy, with a primary focus on its diabetic form, which is one of the most common and serious complications of diabetes mellitus. The study reviews data from various international sources, revealing significant variability in prevalence rates depending on patient populations, diagnostic criteria, and assessment methods. Particular attention is given to the influence of age, disease duration, and diabetes type on the development of autonomic dysfunction. The article also addresses non-diabetic forms of autonomic neuropathy, including amyloid neuropathy. Emphasis is placed on the importance of early diagnosis and a multidisciplinary treatment approach, especially considering the high mortality rate associated with cardiac autonomic neuropathy.

Autonomic neuropathy, diabetic neuropathy, prevalence

Azpiroz F., Malagelada S. (2015) Diabetic intestinal neuropathy: pathogenesis and diagnosis. Diabetologia. doi: 10.1007/s00125-015-3831-1

Intagliata N, Koch KL (2007). Gastroparesis in type 2 diabetes. Diabetes mellitus: prevalence, etiology, diagnosis, and treatment. Carr Gastroenterol Rep 9: 270–279.

Izbeki F, Rostozi A, Varkonyi T, Wittmann T (2012). Clinical studies. Presentation, diagnosis and therapy of gastrointestinal autonomic neuropathy.

Kempler P, Varkonyi T (eds) Neuropathies: A global clinical guideline. Zafir Press, Budapest, pp. 131–150

Kempler P, Ameranko G, Freeman R, et al. (2011) Gastrointestinal tract. autonomic neuropathy, erectile, urinary, and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and treatment. Diabetes Metab ResRev 27: 665–677

Trusov V.V., Danilova M.L. Evaluation of the therapeutic effectiveness of balneotherapy carried out for the purpose of correction of biliary insufficiency in patients with type 2 diabetes // International Journal of Applied and Fundamental Research. 2009. – No. 3. – P.101